甲状腺功能减退症患者应用甲状腺制剂长期替代治疗时,每6~12个月应检测
A 血常规 B
尿常规 C
总T<img border="0" alt="" src="https://img.weimei168.com/uploads/upimg/20221202/11639694_0.gif">、T<img border="0" alt="" src="https://img.weimei168.com/uploads/upimg/20221202/11639694_0_1.gif"> D
游离T<img border="0" alt="" src="https://img.weimei168.com/uploads/upimg/20221202/11639694_0_2.gif">、T<img border="0" alt="" src="https://img.weimei168.com/uploads/upimg/20221202/11639694_0_3.gif"> E
TSH